SEER vs BIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

SEER

64.3
AI Score
VS
SEER Wins

BIO

44.0
AI Score

Investment Advisor Scores

SEER

64score
Recommendation
BUY

BIO

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SEER BIO Winner
Revenue 5.89M 1.24B BIO
Net Income -33.74M -155.70M SEER
Gross Margin 42.2% 52.7% BIO
Net Margin -572.3% -12.5% BIO
Operating Income -34.10M 106.70M BIO
ROE -14.9% -2.2% BIO
ROA -13.1% -1.5% BIO
Total Assets 256.64M 10.25B BIO
Cash 26.07M 517.00M BIO
Current Ratio 14.74 3.14 SEER
Free Cash Flow -25.29M 144.80M BIO

Relative Price Performance (Last 90 Days)

SEER 1M: -8.6% · 3M: +15.0% BIO 1M: +2.5% · 3M: +26.9%

Current Technical Phase

SEER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.8 · Price: $1.96

BIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.2% over 20 days), RSI 53

RSI (14): 52.9 · Price: $371.19

Fundamentals Snapshot

Metric SEER BIO
Market Cap
Forward P/E -1.9 36.8
Trailing P/E 45.9
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin 0.5% 0.5%
Operating Margin -5.4% 0.1%
EPS -1.23 8.21
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SEER is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.